Home » Authors » Trista Morrison

Articles by Trista Morrison

Elixir Raises $46M Series C For Metabolic Disease Trials

Nov. 29, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Sofinnova Closes $375M Fund To Support Spinouts

Nov. 15, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...